Receptos
Receptos, founded in 2009, was a biopharmaceutical company focused on the development of therapeutic candidates for the treatment of immune and inflammatory diseases. Receptos was acquired by Celgene for $7.2B in 2015.
Latest Ä¢¹½ÊÓƵAPP from Receptos
- Receptos Completes $25M Series A Financing 11.23.2009